Advanced Search
Contact | Corporate | Help

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2+ Metastatic Breast Cancer

Sponsors:
  • City of Hope Medical Center
  • GlaxoSmithKline
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Breast Neoplasms
  • HER2 Protein, Human
  • Geriatric Health Services
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Lapatinib
  • Drug: Trastuzumab
Enrollment:
40

Additional information about NCT01273610.


SourceSolution © 2008-2012